Clinical Quiz Answer
What is the Diagnosis?
HM Tam, JY Leung, IFM Lo, HM Luk
What is the diagnosis ?
This child presented with neonatal hypotonia, feeding difficulties, cryptorchidism, speech and motor delay, fair complexion, small hands and feet, and facial dysmorphic features such as narrow bifrontal diameter and almond shaped eyes. All these clinical features are compatible with Prader-Willi syndrome (PWS).
Methylation-specific Multiplex Ligation-dependent Probe Amplification (MS-MLPA) analysis was performed in this child that showed hypermethylation and heterozygous deletion of SNRPN locus in 15q11-q13 region (also known as the Prader-Willi syndrome/Angelman syndrome region, or PWS/AS region). This test confirmed the deletion of the paternally inherited SNRPN allele, thus substantiating the diagnosis of PWS.
What is Prader-Willi syndrome?
Prader-Willi syndrome is a neurodevelopmental disorder which is caused by an absence or disruption of the expression of paternal alleles of SNRPN locus imprinted genes in the PWS/AS region. The prevalence of PWS was found to be 1 in every 15000 to 30000 live births.1
What are the clinical features and diagnosis of Prader-Willi syndrome?
Clinical manifestations of PWS change significantly with age.2 In infants and young children, PWS is characterised by neonatal hypotonia and feeding difficulties which may lead to failure to thrive. When patients grow older, their appetite will increase dramatically and remarkable food-seeking behaviours can be observed. Without food intake restriction, patients would easily become obese and the risk of comorbidities such as type 2 diabetes and cardiovascular diseases would rise. Besides abnormal appetite and weight gain, hypogonadism, global developmental delay, mental retardation, short stature, growth hormone deficiency, sleep apnoea, behavioural and psychological problems such as psychosis and autism are commonly observed in patients of PWS.3-5
Consensus diagnostic criteria of PWS have been established in 1993 and the scoring system is summarised in Table 1. For the full list of diagnostic criteria, one can refer to Prader-Willi syndrome: Consensus Diagnosis Criteria by Holm et al.
What are the genetic mechanisms that lead to PWS?
Three different genetic mechanisms that lead to abnormal expression of paternal alleles in the PWS/AS region, would result in PWS phenotype. Among them, deletions in paternal alleles of 15q11.2-q13 region accounts for around 70-75% of all PWS cases. Other mechanisms include maternal uniparental disomy of chromosome 15 (i.e. both copies of chromosome 15 are maternally inherited, without paternal contribution) (25%), and imprinting defects (1%).6
The exact pathophysiology of PWS is not yet fully understood. It involves multiple imprinted genes that lie within the PWS region in 15q11.2-q13. In a healthy individual, the maternal alleles of some genes in the PWS region are silenced by specific methylation patterns so that the expressed genes in this region are always from paternal origin. However, in PWS patients, the lack of functional paternal alleles leads to a deficiency of their protein products, which brings about various clinical features of PWS.6 For instance, the loss of function of MAGEL2 gene, which is normally highly expressed in the areas of brain that control appetite, can cause dopaminergic dysfunction and hypothalamic leptin insensitivity. It is thus suggested that this gene may be associated with hyperphagia and food-seeking behaviours in PWS.2,7 Table 2 summarises other major candidate genes of PWS and their functions.
The phenotypic manifestations of PWS patients can be correlated to their pathogenic molecular subtype. Generally, patients with deletion mutation have the most prominent clinical features. These patients are more prone to the presentation of neonatal feeding difficulties, hypopigmentation, hypogonadism, small hands and feet, sleep disturbance, articulation defects and more prominent behavioural problems. The average IQ and birthweight of the deletion type are also found to be lower than other PWS patients. All these genotype-phenotype correlation are important for prognosis counselling.12,13
We would like to thank the patient and the family for their contribution.
1. Lionti T, Reid SM, White SM, Rowell MM. A population-based profile of 160 Australians with Prader-Willi syndrome: Trends in diagnosis, birth prevalence and birth characteristics. Am J Med Genet A 2015;167A:371-8.
2. Pravdivyi I, Ballanyi K, Colmers WF, Wevrick R. Progressive postnatal decline in leptin sensitivity of arcuate hypothalamic neurons in the Magel2-null mouse model of Prader-Willi syndrome. Hum Mol Genet 2015;24:4276-83.
3. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatric 1993;91:398-402.
4. Lo ST, Collin PJ, Hokken-Koelega AC. Psychiatric disorders in children with Prader-Willi syndrome - Results of a 2-year longitudinal study. Am J Med Genet A 2015;167A:983-91.
5. Fintini D, Grugni G, Bocchini S, et al. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study. Nutr Metab Cardiovasc Dis 2016;26:842-7.
6. Nicholls RD, Saitoh S, Horsthemke B. Imprinting in Prader-Willi and Angelman syndromes. Trends Genet 1998;14:194-200.
7. Luck C, Vitaterna MH, Wevrick R. Dopamine pathway imbalance in mice lacking Magel2, a Prader-Willi syndrome candidate gene. Behav Neurosci 2016;130:448-59.
8. Li H, Zhao P, Xu Q, et al. The autism-related gene SNRPN regulates cortical and spine development via controlling nuclear receptor Nr4a1. Sci Rep 2016;6:29878.
9. Brilliant MH, King R, Francke U, et al. The mouse pink-eyed dilution gene: association with hypopigmentation in Prader-Willi and Angelman syndromes and with human OCA2. Pigment Cell Res 1994;7:398-402.
10. Andrieu D, Meziane H, Marly F, Angelats C, Fernandez PA, Muscatelli F. Sensory defects in Necdin deficient mice result from a loss of sensory neurons correlated within and increase of developmental programmed cell death. BMC Dev Biol 2006;6:56.
11. Abreu AP, Dauber A, Macedo DB, et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med 2013;368:2467-75.
12. Lin HY, Lin SP, Chuang CK, et al. Genotype and phenotype in patients with Prader-Willi syndrome in Taiwan. Acta Paediatr 2007;96:902-5.
13. Torrado M, Araoz V, Baialardo E, et al. Clinical-etiologic correlation in children with Prader-Willi syndrome (PWS): an interdisciplinary study. Am J Med Genet A 2007;143A:460-8.
This web site is sponsored by Johnson & Johnson (HK) Ltd.